Investment Summary |
|
|---|---|
| Date | 2005-04-01 |
| Target | ACAMS |
| Sector | Education |
| Investor(s) | Warburg Pincus |
| Deal Type | Growth Capital |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1966 |
| PE ASSETS | 83.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Warburg Pincus is a mega-sized, global private equity firm focused on investment opportunities across North America, Asia, and Europe. Warburg will consider investing at various company stages, from early-stage opportunities to distressed situations. Warburg Pincus is organized by industry groups. Verticals include financial services, healthcare, technology, media & telecommunications, energy, consumer & industrial, and real estate. Within financial services, Warburg will consider asset/wealth managers, banks, exchanges, financial technology, insurance, transaction processing, private banking, and specialty/consumer finance. Within healthcare, specific areas of interest include medical devices, healthcare services, and biotech/pharmaceuticals. Within technology/media/communications, Warburg targets software, media/internet/information, financial technology, telecom, business services, and systems/semiconductors. Within energy, specific areas of interest include oil/gas exploration, power generation/transmission, and alternative energy. Warburg Pincus raised its first fund in 1966 and is based in New York City.
| DEAL STATS | # |
|---|---|
| Overall | 78 of 492 |
| Sector: Education M&A | 2 of 7 |
| Type: Growth Capital M&A Deals | 13 of 159 |
| State: Texas M&A | 6 of 40 |
| Country: United States M&A | 50 of 241 |
| Year: 2005 M&A | 8 of 17 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2005-03-29 |
MediaNation
Hong Kong, China MediaNation is a provider of outdoor advertising media services in China and Hong Kong. |
Sell | HK$405M |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2005-04-28 |
Transkaryotic Therapies
Cambridge, Massachusetts, United States Transkaryotic Therapies, Inc. (TKT) is a biopharmaceutical company dedicated to the development and commercialization of products based on its three proprietary development platforms: Gene-Activated proteins, Niche Protein products and Gene Therapy. |
Sell | - |